SJS Investment Consulting »

Nuvectis Pharma shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2026-06-30 $74 4 18.50

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultr Fix Inc Etf (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Eli Lilly & Co. (LLY)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Apple (AAPL)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Hormel Foods Corporation (HRL)
American Centy Etf Tr Avan Tota Eq Etf (AVTM)
Dimensional Etf Trust Global Real Est (DFGR)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us Sustainabilty (DFSU)

View all positions for SJS Investment Consulting

Top funds holding Nuvectis Pharma

Tang Capital Management
BlackRock
Soleus Capital Management
Perceptive Advisors
Vanguard Capital Management
Iridian Asset Management
Geode Capital Management
Sphera Funds Management
Baldwin Brothers
Occam Crest Management
Susquehanna International
Alyeska Investment Group
Avidity Partners Management
Citadel Advisors
State Street Corporation

View all funds holding Nuvectis Pharma